Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Clinical Lab Management › In Coronavirus Assay Validation for Emergency Use, Labs Encounter Multiple Pain Points

In Coronavirus Assay Validation for Emergency Use, Labs Encounter Multiple Pain Points

Mar 11, 2020
|
Madeleine Johnson

This story has been updated to include additional manufacturing capabilities of authorized reagent suppliers.

NEW YORK – Labs developing their own assays for SARS-CoV-2 virus detection in patients are coming across unexpected bottlenecks and hurdles as they rush toward US Food and Drug Administration emergency use authorization.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In PCR

  1. Faced With Confusion, Questionable Claims, FDA Addresses Coronavirus Serology Testing

  2. FDA Grants Emergency Use Authorization for BD Coronavirus Test Kit

  3. With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

  4. FDA Issues Emergency Use Authorization for Viracor Eurofins Coronavirus LDT

  5. DiaCarta Gets FDA Emergency Use Authorization for Coronavirus PCR Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.